Clinician discussing musculoskeletal injection therapy with a patient
Project Status: HRA Approved · 8 September 2026

MSK Injection Therapies

Outcomes and Safety Delivered as Routine Care

HRA ApprovedREC 26/SW/0096
IRAS 375544Project ID
Observational CohortProspective · Routine Care

Regulatory & Ethics Approval

Approved for Ethical, Evidence-Led Research.

Study Identification

A Prospective Observational Cohort Study of the Outcomes and Safety of Musculoskeletal Injection Therapies Delivered as Routine Care

REC Reference

26/SW/0096

IRAS Project ID

375544

Favourable Opinion

8 September 2026, confirmed on further information

NHS

Health Research
Authority

South West - Frenchay Research Ethics Committee

Ground Floor

Temple Quay House

2 The Square

Bristol

BS1 6PN

REC 26/SW/0096

Ethics approval letter · REC 26/SW/0096

Open full size
Research ethics committee approval letter for A Prospective Observational Cohort Study of the Outcomes and Safety of Musculoskeletal Injection Therapies Delivered as Routine Care

About the Study

Measuring what routine injection care actually delivers.

Musculoskeletal injection therapies are used every day to relieve pain and restore function in joints, tendons and soft tissue. This prospective observational cohort study follows patients who receive those injections as part of their normal care at MSK Doctors, recording their outcomes and any safety events over time.

Because the study is observational, nothing about a patient's treatment changes by taking part. The aim is to build a transparent, real-world evidence base for how these therapies perform outside the controlled conditions of a clinical trial.

Protocol details

Cohort size, follow-up schedule and outcome measures will be published here as the study opens to participants. For the approved protocol, contact the research team.

Observational, not interventional

Treatment decisions are made exactly as they would be in routine care. The study records what happens; it does not change which injection a patient receives.

Outcomes and safety together

Patient-reported outcomes and any adverse events are collected prospectively, so benefit and safety are measured on the same cohort.

Real-world practice

Data comes from injections delivered as part of everyday clinical care rather than a tightly selected trial population.

Ethically approved

The study holds a favourable opinion from an NHS Health Research Authority research ethics committee and follows the UK Policy Framework for Health and Social Care Research.

Taking Part

Receiving injection therapy
at MSK Doctors?

Patients treated with musculoskeletal injection therapies as part of routine care may be invited to contribute their outcomes. Ask your clinician, or contact the research team directly.

Privacy & Cookies Policy